سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Evaluation of Tumor Markers in Endometrial Cancer Differentiation and Abnormal Uterine Bleeding

سال انتشار: 1403
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 53
این مقاله فقط به صورت چکیده توسط دبیرخانه ارسال شده است و فایل کامل قابل دریافت نیست. برای یافتن مقالات دارای فایل کامل، از بخش [جستجوی مقالات فارسی] اقدام فرمایید.

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

ICGCS02_147

تاریخ نمایه سازی: 17 دی 1403

چکیده مقاله Evaluation of Tumor Markers in Endometrial Cancer Differentiation and Abnormal Uterine Bleeding

Endometrial cancer is recognized as the most frequently diagnosed malignancy of the female genital system. It is imperative to evaluate the discriminatory ability of specific tumor markers, namely, the Carcinoembryonic Antigen (CEA), Cancer Antigen 15-3 (CA 15-3), and Cancer Antigen 125 (CA-125). This evaluation becomes particularly significant in situations where patients exhibit symptoms of abnormal uterine bleeding (AUB). Our investigation evaluates of tumor markers in endometrial cancer differentiation and AUB. Methods & Materials: A comprehensive search was conducted utilizing reputable databases including Ovid, Elsevier, PubMed, and Google Scholar. The search encompassed literature published from the year 2014 to 2023 and was not restricted by language. A total of 30 articles were initially identified, and after thorough summarization and analysis, 20 articles were deemed relevant and selected for inclusion. Results: Upon meticulous examination of the data, it was discerned that the variation in serum concentrations of the CEA tumor marker in patients afflicted with endometrial cancer was of statistical significance. This observation was substantiated by a preponderance of the studies reviewed, which reported a statistically significant discrepancy in serum concentrations of the CEA tumor marker between patients diagnosed with endometrial cancer and those presenting with abnormal uterine bleeding. However, a comprehensive meta-analysis incorporating five distinct trials failed to establish a significant difference when comparing serum concentrations of the CA 15-3 and CA-125 tumor markers in patients diagnosed with endometrial cancer and those exhibiting symptoms of abnormal uterine bleeding. Conclusion: Drawing upon the extant body of evidence, it can be postulated that the CEA marker may be judiciously utilized for the initial detection of endometrial cancer. Moreover, it could potentially be instrumental in the systematic monitoring of therapeutic progress among patients who have been diagnosed with this specific form of malignancy.

کلیدواژه های Evaluation of Tumor Markers in Endometrial Cancer Differentiation and Abnormal Uterine Bleeding:

نویسندگان مقاله Evaluation of Tumor Markers in Endometrial Cancer Differentiation and Abnormal Uterine Bleeding

Reyhaneh Aftabi

Clinical Research Development Unit, Kowsar Hospital, Urmia University of Medical Sciences, Urmia, Iran

Somayeh Ghasemzadeh

Clinical Research Development Unit, Kowsar Hospital, Urmia University of Medical Sciences, Urmia, Iran

Aysan Dehghani

Clinical Research Development Unit, Kowsar Hospital, Urmia University of Medical Sciences, Urmia, Iran

Milad Hejazi

Clinical Research Development Unit, Kowsar Hospital, Urmia University of Medical Sciences, Urmia, Iran